Studies from Temple University Health System in the Area of Bladder Cancer Described [Sequential Intravesical Gemcitabine-docetaxel Vs. Bacillus Calmette-guerin (Bcg) In the Treatment of Non-muscle Invasive Bladder Cancer: a Preliminary ...]

Media coverage

• Title	Studies from Temple University Health System in the Area of Bladder Cancer Described [Sequential Intravesical Gemcitabine-docetaxel Vs. Bacillus Calmette-guerin (Bcg) In the Treatment of Non-muscle Invasive Bladder Cancer: a Preliminary ...]
  Media name/outlet	Health Policy and Law Daily
  Country/Territory	United States
  Date	11/2/23
  Persons	Alexander Kutikov, Robert G. Uzzo, Philip Abbosh, Marc C. Smaldone